Wyeth Prempro breast cancer suit in deliberations NIH funds study on patient comliance Leavitt sees room for compromise on SCHIP BioSante completes FDA required studies of LibiGel FluMist may be used in $2.5 billion federal program FDA approves new form of Lamisil Eli Lilly updates product labels Merck wins Florida liability suit Teva releases generic Coreg Study suggests soy protien may help reduce risk of prostate cancer First Previous 1556 1557 1558 1559 1560 Next Last